LDL-Apheresis for FSGS CardioRenal Outcomes
Condition: Focal Segmental Glomerulosclerosis Intervention: Other: No intervention Sponsors: Children's Hospital Medical Center, Cincinnati; Kaneka Pharma America LLC Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials